← Leaderboards
Blake J Roessler
University Of Michigan At Ann Arbor
$2,775,203
Attributed
$2,775,203
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $401.9K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,775,203 · 9
By mechanism
P30$827,141 · 2
R01$729,807 · 1
P01$428,807 · 1
N01$408,928 · 1
R21$378,757 · 1
M01$1,763 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Scott Hall Visovatti$931,578
- Steven R King$830,795
- David Alan Fox$8,525,791
- Bruce C. Richardson$11,674,875
- Robert Gerard$230,454
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyIn VivoGene TherapyCost EffectivePlasmidsQualifyingCostReagentGuidelinesMolecular BiologyAdenovirusesIn VitroLaboratoriesMemberProductionEnsureInterestMonitorBiological ContainmentCellsGene TransferGene Transfer VectorGenesPrograms
Grant awards (23)
Transcutaneous Raman Spectroscopy for Diagnosis of Diabetic Osteomyelitis$185,632
R21 · FY2011 · EB · contact PI
Transcutaneous Raman Spectroscopy for Diagnosis of Diabetic Osteomyelitis$193,125
R21 · FY2010 · EB · contact PI
VECTOR CORE$138,795
P30 · FY2010 · CA · contact PI
Vector Core$69,953
P30 · FY2010 · AR · contact PI
VECTOR CORE$137,907
P30 · FY2009 · CA · contact PI
Vector Core$69,669
P30 · FY2009 · AR · contact PI
VECTOR CORE$76,502
P30 · FY2008 · CA · contact PI
Vector Core$68,413
P30 · FY2008 · AR · contact PI
VECTOR CORE$76,502
P30 · FY2007 · CA · contact PI
Vector Core$36,898
P30 · FY2007 · AR · contact PI
VECTOR CORE$76,502
P30 · FY2006 · CA · contact PI
Vector Core$38,000
P30 · FY2006 · AR · contact PI
MOLECULAR SYNOVECTOMY BY IN VIVO GENE TRANSFER: A PHASE I TRIAL$539
M01 · FY2006 · RR · contact PI
MOLECULAR SYNOVECTOMY BY IN VIVO GENE TRANSFER: A PHASE I TRIAL$1,018
M01 · FY2005 · RR
GENE THERAPY FOR HEMOPHILIA B$370,075
R01 · FY2003 · HL
GENE THERAPY FOR HEMOPHILIA B$359,732
R01 · FY2002 · HL
CORE--TRANSFECTION VECTOR$115,227
P01 · FY2002 · CA
CORE--VECTOR FACILITY$0
P30 · FY2002 · AR
CORE--TRANSFECTION VECTOR$115,227
P01 · FY2001 · CA
CORE--VECTOR FACILITY$38,000
P30 · FY2001 · AR
MECHANISMS OF PERIFOLLICULAR TRANSFECTION$408,928
N01 · FY2000 · AR
CORE--TRANSFECTION VECTOR$198,353
P01 · FY2000 · CA
MOLECULAR SYNOVECTOMY BY IN VIVO GENE TRANSFER$206
M01 · FY2000 · RR